Henry J. Pankratz

Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany

Part of Thermo Fisher Scientific, Inc., Ionalytics Corp. designs and manufactures ion-filtering equipment and related engineering instruments. The company is based in Ottawa, Canada. Ionalytics was acquired by Thermo Electron Corp. on August 11, 2005.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto.

Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy.

Virgin Health Bank Ltd. provides umbilical cord blood stem cell banking services. It offers family banking and community banking. The company was founded in 2009 and is headquartered in London, the United Kingdom.

Vernalis Group, Inc. provides custom software and tech solutions.

SmartWard Pty Ltd. develops software for the healthcare industry. The company was founded by Lindsay Bevege in 2012 and is headquartered in Bruce, Australia.

Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK.

Part of Gilead Sciences, Inc., DELEX Therapeutics, Inc. is a Canadian company that researches and develops inhalation pain treatment products for cancer patients. The company is based in Mississauga, Canada. DELEX Therapeutics was acquired by YM BioSciences, Inc. on May 03, 2005 for $7.60 million.

Flosonics Medical develops and operates medical software platform for the management of critically ill patients. The company was founded by Joe Eibl, Jon-Emile Kenny, Andrew Eibl, and Sachit Harish and is headquartered in Sudbury, Canada.

Rolls-Royce Corp. manufactures automobile. It designs, engineers, and manufactures aircraft, industrial and marine engines. The company was Incorporated on October 12, 1993 and is headquartered in Indianapolis, IN.

Performance Plants, Inc. discovers and develops second generation agricultural biotechnologies. The firm’s patented technologies enhance plant productivity (including seed yield and plant biomass) and weatherproof food and non-food biofuel crops through periods of drought and heat stresses resulting in a more abundant, consistent and cost-effective harvests for farmers. Its technology products include yield protection technology, heat & drought tolerance technology, technology development pipeline and trait technology stacking. The company was founded by David Dennis in 1995 and is headquartered in Kingston, Canada.

Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006.

Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA.

Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA.

Orthomimetics brings a new dimension to the treatment of joints damaged through sport or other orthopaedic trauma. Its heritage is a trans-Atlantic collaboration between two world-leading academic institutions, the University of Cambridge and the Massachusetts Institute of Technology (MIT), who have each contributed 30 years of experience to the repair of bone and soft tissues respectively. The harnessing of their expertise into viable therapeutic medical products is the foundation of Orthomimetics.

Chiroxia Ltd. is an Irish private company located in Dublin. The firm provides legal services.

Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.

Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.

GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada.

Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.

The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom.

Excalibur Group Holdings Ltd. is a private company based in London, UK. and has subsidiaries in the United Kingdom, the British Virgin Islands, Germany and Sweden. The British company was founded by Christopher Thomas Evans.